Testosterone Replacement Therapy and Cardiovascular Risk—A Closer Look at Additional Parameters

2017 ◽  
Vol 177 (9) ◽  
pp. 1393 ◽  
Author(s):  
Konstantinos Stavropoulos ◽  
Konstantinos P. Imprialos ◽  
Michael Doumas
Andrology ◽  
2020 ◽  
Vol 8 (6) ◽  
pp. 1614-1627 ◽  
Author(s):  
Franz Sesti ◽  
Riccardo Pofi ◽  
Marianna Minnetti ◽  
Marta Tenuta ◽  
Daniele Gianfrilli ◽  
...  

2010 ◽  
Vol 9 (1) ◽  
pp. 59
Author(s):  
Polackwich AS ◽  
Tadros NN ◽  
Ostrowski KA ◽  
◽  
◽  
...  

Late onset hypogonadism (LOH) is an issue of increasing concern. Studies have shown the importance of testosterone in the maintenance of homeostasis, especially with respect to bone health, sexual function, diabetes, cardiovascular risk, mental health and cognition. Much of the dysfunction in hypogonadism can be reversed or improved with testosterone replacement therapy (TRT). Physicians worry about the possible consequences of TRT, especially regarding the prostate. By reviewing the literature, we have found there are significant benefits to TRT, and fears of adverse effects on the prostate are largely unfounded, though there is a great need for larger studies with longer periods of follow-up, especially to evaluate adverse events.


2016 ◽  
Vol 34 (2) ◽  
pp. 154 ◽  
Author(s):  
Giovanni Corona ◽  
Giulia Rastrelli ◽  
Elisa Maseroli ◽  
Alessandra Sforza ◽  
Mario Maggi

2015 ◽  
Vol 33 (3) ◽  
pp. 130 ◽  
Author(s):  
Giovanni Corona G ◽  
Giulia Rastrelli ◽  
Elisa Maseroli ◽  
Alessandra Sforza ◽  
Mario Maggi

Sign in / Sign up

Export Citation Format

Share Document